Tiger Global Trims Big Tech, Rotates Into SpaceX as Private Markets Absorb Capital

Tiger Global Management's latest position disclosures reveal a deliberate shift in the crossover fund's centre of gravity: reduced exposure to the mega-cap technology names that have driven index returns, redeployed in part into a stake in SpaceX. The move is emblematic of a structural trend rather than a single manager's tactical call. With public AI and platform multiples having absorbed years of forward growth, the marginal risk-adjusted opportunity increasingly sits in late-stage private vehicles where entry prices are negotiated rather than auctioned. That calculus is reinforced by the current public-market drawdown in AI hardware, which has demonstrated how rapidly crowded consensus positions can gap lower. The disclosure cycle also captured congressional and retail-adjacent activity — sales of Apple and MicroStrategy shares, disposals across Pfizer, Quest Diagnostics, Target and U.S. Bancorp, and fixed-income purchases in Capital One and HCA notes — sketching a broader picture of de-risking from equity beta into credit and cash-flow assets. Taken together, the flow data suggests sophisticated capital is neither capitulating nor chasing, but repositioning toward assets with less mark-to-market sensitivity.